![](/static/images/dhcircle_logo.png)
DecisionHealth, DecisionHealth - 2014 Issue 3 (March)
Benchmark: Practices billed newly covered chemo codes millions of times in 2012
Practices that are able to use an oral three-drug regimen for treating nausea in cancer patients receiving chemotherapy drugs including
J9263
(Oxaliplatin) and
J9025 (Azacitidine) could see new revenue in May.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.
Official DecisionHealth® Newsletter Archives includes:
- Includes over 25,000 articles from:
- Coder Pink Sheets
- Part B News
- Answer Books newsletters
- Current newsletters added each quarter
- Timely news and guidance vital for your practice
- Fully searchable through Find-A-Code's Comprehensive Search
- Codes mentioned in articles are linked to the Find-A-Code Code Information pages
- Code Information pages link back to related articles
- Save yourself tons of research time, find everything in one place!
Access to this feature is available in the following products:- DecisionHealth Coding, Billing and Compliance Library
|
Thank you for choosing Find-A-Code, please Sign In to remove ads.